Stem cell hope for Kids' arthritis withdrawn before start
NCT ID NCT06623240
Summary
This study aimed to test if infusions of donor stem cells (HB-adMSCs) could safely reduce joint pain and swelling in children with juvenile idiopathic arthritis. It planned to enroll 66 children aged 2-17 and compare the stem cell treatment against a placebo. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS (JIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.